Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration [Corrigendum]
Michalska-Małecka K, Kabiesz A, Kimsa MW, et al. Clin Interv Aging. 2016;11:357–365.
On page 358, Materials and methods, Subjects section. The ethics statement was “The study was approved by the Bioethics Committee of the Medical University in Katowice (KNW) in accordance with the Declaration of Helsinki regarding medical research involving human subjects”, the corrected ethics statement is “The study was approved by the Bioethical Committee of Medical University of Silesia (approval number: KNW/0022/KB1/38/I/15) and is consistent with the Declaration of Helsinki”.
Read the original article.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]